Paget's Disease News and Research

RSS
Paget’s disease of the bone is a chronic ailment affecting the skeleton. Sir James Paget described Paget's disease of bone in 1877 and the disease is named after him. This is a rare disease affecting 1% of the population in the United States. It commonly affects the elderly and nearly 3 to 4% of the population over age 50 are affected.
Teeth may be able to preserve antibodies for hundreds of years, study reveals

Teeth may be able to preserve antibodies for hundreds of years, study reveals

Researchers are developing calculator that weighs risk and benefit of taking osteoporosis drugs

Researchers are developing calculator that weighs risk and benefit of taking osteoporosis drugs

Medical societies publish guidelines on how to treat pre-invasive lesions of the vulva

Medical societies publish guidelines on how to treat pre-invasive lesions of the vulva

Calcified Tissue International announces top 10 most impactful papers of 2019

Calcified Tissue International announces top 10 most impactful papers of 2019

Older men are underdiagnosed and undertreated for osteoporosis

Older men are underdiagnosed and undertreated for osteoporosis

Researchers discover key signaling pathway in the pathogenesis of Paget's disease

Researchers discover key signaling pathway in the pathogenesis of Paget's disease

Reviews provide overview of advances in the knowledge of focal and sclerotic bone diseases

Reviews provide overview of advances in the knowledge of focal and sclerotic bone diseases

Research findings suggest potential strategies to combat IBMPFD and other degenerative diseases

Research findings suggest potential strategies to combat IBMPFD and other degenerative diseases

New article shows taxonomic classification of rare genetic bone disorders based on metabolic phenotypes

New article shows taxonomic classification of rare genetic bone disorders based on metabolic phenotypes

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Shire announces availability of Natpara (parathyroid hormone) for injection in U.S.

Endocrine Society issues Clinical Practice Guideline on rare bone condition

Endocrine Society issues Clinical Practice Guideline on rare bone condition

Researchers discover link between NOX4 enzyme and osteoporosis

Researchers discover link between NOX4 enzyme and osteoporosis

VCP gene mutations cause neurological conditions including IBMPFD and ALS

VCP gene mutations cause neurological conditions including IBMPFD and ALS

Study identifies how new ALS gene mutations cause other diseases of the brain, muscle and bone

Study identifies how new ALS gene mutations cause other diseases of the brain, muscle and bone

Osteoporosis medication Aclasta now available on Canadian public drug plans

Osteoporosis medication Aclasta now available on Canadian public drug plans

New mouse model could foster ALS, Paget's and dementia breakthroughs

New mouse model could foster ALS, Paget's and dementia breakthroughs

FDA reviews safety issues of bisphosphonates for osteoporosis

FDA reviews safety issues of bisphosphonates for osteoporosis

Eli Lilly, Synthes collaborate to develop osteoinductive products

Eli Lilly, Synthes collaborate to develop osteoinductive products

Bone building drugs bisphosphonates lead to only a marginally higher risk of fractures: Study

Bone building drugs bisphosphonates lead to only a marginally higher risk of fractures: Study

IOF, ANZBMS to hold osteoporosis and bone meeting in Asia-Pacific region

IOF, ANZBMS to hold osteoporosis and bone meeting in Asia-Pacific region

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.